Solvay sells Caprolactones unit for 200 mln euros

BRUSSELS Mon Oct 15, 2007 2:42am EDT

BRUSSELS Oct 15 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR) said on Monday it had sold its Caprolactones business for 200 million euros ($284.3 million) to Sweden's Perstorp Group.

The transaction is expected to be completed in the fourth quarter of 2007, pending regulatory approvals.